Hydroxychloroquine, Vitamin D,  blood thinners, and Remdesivir's  effectiveness against COVID-19 have a common link
Creators: name: Anthony of Boston (Anthony Moore)
Publisher: name: Zenodo
Year: 2020
Subjects: Hydroxychloroquine
covid 19
coronavirus

description: Hydroxychloroquine, Vitamin D, blood thinners, and Remdesivir's effectiveness against COVID-19 have a common link



US President Trump has advocated for Hydroxychloroquine to be considered as an effective treatment for COVID-19. However, after a number of people have been reported to experience serious adverse side effects, the general consensus has-as a result- turned largely pessimistic about Hydroxychloroquine's effectiveness. The reason I considered the recommendation of a malaria drug as solid reasoning is based on my research in making sense of how overall health is divided mainly into two opposing sides. This is explained in Chapter 27 of Ares Le Mandat. The lineup of symptoms, vitamins, and minerals on one side can each fight against the symptoms, vitamins and minerals of the other side. My reasoning infers that because Vitamin E is designated to side one of health in Chapter 27, while flu is designated to side two, Vitamin E can easily be nominated as a candidate for treatment of anything flu-like(I infer COVID-19 as a flu-like illness). Because its hypothesized that anything on side one can fight against anything on side two, theoretically-as a result of that-any symptom, vitamin or mineral from side one is a contender to fight against any symptom, vitamin or mineral on side two. Judging from the way the components(symptom, vitamin or mineral) of each side is allocated- with high insulin on side one versus both flu and malaria on side two(see pg 533-534 of Chapter 27 of Ares Le Mandat)- Hydroxychloroquine with its high insulin/hypoglycemic side effect becomes a solid proposal in the fight against COVID-19. After reading about the fatal cases pertaining to Hydroxychloroquine use, I learned that the adverse effects mirrored strongly the adverse affects of extreme hypoglycemia and insulin overdose which both normally end in cardiac arrest. This is not the case for all reported treatments of COVID-19 with Hydroxychloroquine. Hydroxychloroquine has been found effective in some studies. Treatment with Hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System. https://www.henryford.com/news/2020/07/hydro-treatment-study


What Hydroxychloroquine does-in terms of how it applies to the Chapter 27 perspective-is draw from the high insulin component of side one and uses that to fight against the components of side two. Furthermore, it should not be surmised that this infers for a component of one side to be without problems should it be administered beyond what is necessary for treatment. This is happening with use of Hydroxychloroquine in some cases. A good analogy is drinking not just enough water just to satisfy one's thirst, but drinking too much to not only satisfy one's thirst but also go overboard and at the same time bring oneself to water intoxication. In this, one can understand such a scenario doesn't discount water altogether as an effective treatment for thirst. The key for any further research on Hydroxychloroquine would be in understanding the individual patient's initial level of insulin and administering based on that in order to circumvent the dangers of the hypoglycemia/high insulin overdose symptom of Hydroxychloroquine's adverse effects.


Moreover, what Chapter 27 of Ares Le Mandat does is show why there is more than one effective method to fight COVID-19 or any other disease.


Update: Another example that affirms the side 1/side 2 layout of health described in Chapter 27 of Ares Le Mandat are the promising results that Vitamin D has shown in coronavirus research. Studies performed by Michael F. Holick--a professor of physiology, medicine and molecular medicine and biophysics at Boston University School of Medicine--found that COVID-19 patients over 40 who had sufficient Vitamin D levels were  51% less likely to die from the virus. It was also concluded that anyone who had sufficient levels of Vitamin D in his system had a reduced risk of catching the virus by 54%. Pages 533 and 534 of Chapter 27 of Ares Le Mandat has Vitamin D lined up on the same side of health as high insulin, which was the effect of Hydroxychloroquine protocols used to fight COVID-19. This further affirms the outlook of 2 opposing sides of health.


The success of blood thinners in treating COVID 19 also affirms the side 1/side 2 layout of health described in Chapter 27 of Ares Le Mandat. An observational study done by researchers at Mount Sinai in New York found that hospitalized COVID-19 patients who took blood thinner prescriptions had a 50% reduced risk of death. They also checked autopsy records from COVID-19 patients at Mount Sinai and found that 11 of 26 patients had blood  clots  in  the  lungs,  brain  and  heart  that  weren’t  detected  in  the  hospital. https://www.webmd.com/lung/news/20200827/blood-thinners-may-increase-covid-survival-rates Scientists  at Rensselaer Polytechnic Institute discovered the effectiveness of blood thinners in neutralizing the coronavirus. They found that the blood thinner heparin was effective in keeping the virus from infecting healthy cells.  https:// www.fiercebiotech.com/research/how-covid-19-could-be-crippled-by-age-old-blood-thinner The  studies concerning blood thinners as an effective treatment justifies the Vitamin E proposal since it also has blood thinning properties. Pages 533 and 534 of Chapter 27 of Ares Le Mandat has blood thining lined up on the same side of health as Vitamin D and high insulin.


On October 2, 2020, US President Donald Trump announced that he and the First Lady tested positive for Covid-19.  He has been placed on a five-day course of treatment with remdesivir, an antiviral drug manufactured by  drug maker company  Gilead  Sciences.  One  can  gather  from  information regarding  the side effects  of remdesivir that remdesivir is also drawing from the side 1 of health explained in Chapter 27 of Ares Le Mandat, specifically from the gastroproblems that has been set as antagonistic to flu-like illnesses. The most common side effect discovered in patients treated for COVID-19 using  remdesivir  was nausea. This, according to the thesis outlined in Chapter 27 of Ares Le Mandat, makes remdesivir a solid proposal against the coronavirus. In a 600-patient analysis, published by the Journal of the American Medical Association, the study in moderately ill COVID-19 patients showed that 11 days after starting treatment--65% of the 10-day remdesivir patients, 70% of the 5-day patients and 60% of the standard care patients had left the hospital. “Side effects seen more frequently in  the  remdesivir  groups  included  nausea,  low  blood  potassium  levels,  and  headache.” https://www.reuters.com/article/us-health-coronavirus-remdesivir/gilead-fda-could-expand-remdesivir-use-
despite-mixed-data-idUSKBN25H2CT Pages 533 and 534 of Chapter 27 of Ares Le Mandat has gastroproblems lined up on the same side of health as  blood thining,  Vitamin D, and high insulin.


This  thesis  of  overall  health  being  divided  mainly  into  two  opposing  sides  makes  sense  of  how Hydroxychloroquine(high insulin effect), Vitamin D, blood thinners, and  remdesivir(gastroproblem effect) are all effective against the coronavirus (COVID-19).


this is Chapter 27 of Ares Le Mandat which explains health  being  divided  mainly  into  two  opposing sides https://zenodo.org/record/3620801#.XyBNUp5KjIU